Figure 2
From: Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus
Comparison of survival of all patients undergoing surgery alone and NT + surgery. Median survival time was 13.9 and 20.3 months, respectively.
Figure 2 | BMC Cancer